DMD and Duchenne muscular dystrophy: Recent investigations have reported a limitation in designing efficient antisenses to induce human dystrophin skipping in a mice model assay [25]; however, we confirmed the feasibility of direct translation of an antisense PMO from a DMD dog model to a DMD patient, at least in vitro, for the first time.